Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Stryker Leibinger GmbH & Co. KG

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Stryker Leibinger GmbH & Co. KG

Regulatory records
8
Linked recall entries
1
Headquarters
Not reported
Brand website
stryker.com
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 8 FDA records to the applicant name Stryker Leibinger GmbH & Co. KG. The collection includes 4 510(k) clearances. 4 entries are PMA supplements. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jul 23, 2025 to Jul 15, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code LZD appears in 2 of the 8 linked filings. The collection spans 5 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P130014, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: Boetzinger Strasse 41, Freiburg, D-7911. Recorded on P130014/S022, decision dated Jul 15, 2026.

Changes described in PMA records

P130014/S022: Adherus AutoSpray Dural Sealant; Adherus AutoSpray ET Dural Sealant

FDA’s recorded scope: The Adherus AutoSpray Dural Sealant and Adherus AutoSpray ET Dural Sealant are indicated for use in patients who are 13 years of age and older, as an adjunct to standard methods of dural repair, such as sutures, to provide watertight closure during cranial and spinal procedures.

Jul 15, 2026 · Panel Track

P130014/S021: Adherus AutoSpray Dural Sealant

FDA’s recorded scope: Approval for use of an automated vial filling system and to perform a packaging step outside of a glove box.

Nov 6, 2025 · 135 Review Track For 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

RECALL COVERAGE

Recalls linked to this firm

MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.

Recall / productCompanyClassificationReport dateSource
Stryker Leibinger GmbH & Co. KGClass IINov 4, 2026FDA

Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.

Source information

Source updated Nov 11, 2026. Retrieved Nov 21, 2026.

Regulatory record history

Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.